SUGGESTIONS FOR HER-2/neu TESTING IN BREAST CARCINOMA, BASED ON A COMPARISON OF IMMUNOHISTOCHEMISTRY AND FLUORESCENCE IN SITU HYBRIDISATION

By Field A.S.   Chamberlain N.L.   Tran D.   Morey A.L.  

Pathology, Vol. 33, Iss. 3, 2001-08 ,pp. : 278-282

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Chromogenic in situ hybridisation testing for HER2 gene amplification in breast cancer produces highly reproducible results concordant with fluorescence in situ hybridisation and immunohistochemistry

By Bilous Michael   Morey Adrienne   Armes Jane   Cummings Margaret   Francis Glenn  

Pathology, Vol. 38, Iss. 2, 2006-04 ,pp. : 120-124

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Recommendations for lipid testing and reporting by Australian pathology laboratories

By Hickman Peter E.  

Pathology, Vol. 39, Iss. 3, 2007-01 ,pp. : 297-298

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Correlation of Mammographic Calcifications with HER-2/neu Overexpression in Primary Breast Carcinomas

By Wang X.  

Journal of Digital Imaging, Vol. 21, Iss. 2, 2008-06 ,pp. : 170-176

Springer Publishing Company

Access to resources Recommend Favorite

Influence of valency and labelling chemistry on in vivo targeting using radioiodinated HER2-binding Affibody molecules

By Tolmachev Vladimir  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 36, Iss. 4, 2009-04 ,pp. : 692-701

Springer Publishing Company

Access to resources Recommend Favorite